2025-12-01 Drugs Global Leadership for Increasing Patient Accessibility, SFDA Expands Lojuxta Indication to Include Treatment of Children with Homozygous Familial Hypercholesterolemia (HoFH)
2025-11-24 Drugs SFDA Connects National Pharmacovigilance Database to WHO Global Platform, Strengthening Drug Safety
2025-11-10 Drugs SFDA Approves the Registration of “Pemazyre” for the Treatment of Bile Duct Cancer in Adults
2025-10-30 Drugs SFDA CEO Launches “RASID” Smart Service for Verifying Controlled Medications Carried by Visitors to Saudi Arabia
2025-10-30 The Authority, Drugs SFDA CEO Launches National Network for Drugs and Medical Products Safety During Pregnancy and Breastfeeding
2025-10-29 The Authority, Drugs SFDA CEO Launches an AI Model to Proactively Predict Drug Shortages in Saudi Arabia
2025-10-27 The Authority, Drugs SFDA CEO Launches the Saudi Pharmacopoeia on the Sidelines of the Global Health Exhibition
2025-10-26 The Authority, Drugs First from the Middle East and North Africa: ICMRA Announces Saudi Arabia as a Full Member
